MCID: RCR004
MIFTS: 38

Recurrent Respiratory Papillomatosis malady

Rare diseases, Respiratory diseases categories

Aliases & Classifications for Recurrent Respiratory Papillomatosis

About this section
Sources:
45NIH Rare Diseases, 51Orphanet, 65UMLS, 37MESH via Orphanet, 66UMLS via Orphanet
See all sources

Aliases & Descriptions for Recurrent Respiratory Papillomatosis:

Name: Recurrent Respiratory Papillomatosis 45 51 65
Juvenile-Onset Recurrent Respiratory Papillomatosis 45
Adult-Onset Recurrent Respiratory Papillomatosis 45
Respiratory Papillomatosis, Recurrent 45
Laryngeal Papilloma, Recurrent 45
 
Juvenile Laryngeal Papilloma 45
Jorrp 45
Aorrp 45
Rrp 45


Classifications:



External Ids:

Orphanet51 60032
MESH via Orphanet37 C535297
UMLS via Orphanet66 C1168198

Summaries for Recurrent Respiratory Papillomatosis

About this section
NIH Rare Diseases:45 Recurrent respiratory papillomatosis (rrp) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). although the tumors can grow anywhere in the respiratory tract, their presence in the larynx (voice box) causes the most frequent problems, a condition called laryngeal papillomatosis. the tumors may vary in size and grow very quickly. they often grow back even when removed. rrp is caused by two types of human papillomavirus (hpv), called hpv 6 and hpv 11. last updated: 11/21/2011

MalaCards based summary: Recurrent Respiratory Papillomatosis, also known as juvenile-onset recurrent respiratory papillomatosis, is related to papilloma and squamous cell papilloma. An important gene associated with Recurrent Respiratory Papillomatosis is HLA-DRB1 (Major Histocompatibility Complex, Class II, DR Beta 1), and among its related pathways are Staphylococcus aureus infection and IL12 signaling mediated by STAT4. Affiliated tissues include lung, t cells and testes, and related mouse phenotype liver/biliary system.

Related Diseases for Recurrent Respiratory Papillomatosis

About this section

Diseases related to Recurrent Respiratory Papillomatosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 113)
idRelated DiseaseScoreTop Affiliating Genes
1papilloma10.8
2squamous cell papilloma10.7
3squamous papillomatosis10.7
4respiratory system disease10.7
5laryngeal papillomatosis10.6
6larynx squamous papilloma10.5
7laryngeal benign neoplasm10.5
8laryngeal carcinoma10.5
9laryngeal disease10.5
10laryngitis10.4
11gastroesophageal reflux10.3
12pharyngitis10.3
13auditory system disease10.3
14cell type benign neoplasm10.3
15pharynx cancer10.3
16respiratory system benign neoplasm10.3
17tucker syndrome10.2HLA-DQB1, HLA-DRB1
18best1 retinopathy10.2HLA-DQB1, HLA-DRB1
19lichen planus pemphigoides10.2HLA-DQB1, HLA-DRB1
20microsomia hemifacial radial defects10.2HLA-DQB1, HLA-DRB1
21heavy chain deposition disease10.2HLA-DQB1, HLA-DRB1
22autoimmune polyglandular syndrome type 210.2HLA-DQB1, HLA-DRB1
23childhood cerebellar astrocytic neoplasm10.2HLA-DQB1, HLA-DRB1
24lung cancer10.2
25asthma10.2
26anemia, sideroblastic, pyridoxine-refractory, autosomal recessive10.2
27esophageal cancer10.2
28aspergillosis10.2
29czech dysplasia10.2
30retinoblastoma10.2
31speech and communication disorders10.2
32common wart10.2
33mumps10.2
34sensorineural hearing loss10.2
35dyskinesia of esophagus10.2
36eye carcinoma10.2
37spastic diplegia10.2
38laryngotracheitis10.2
39squamous cell papilloma of skin10.2
40measles10.2
41rubella10.2
42central nervous system cancer10.2
43esophageal disease10.2
44esophagitis10.2
45eye disease10.2
46globe disease10.2
47herpes simplex10.2
48lung squamous cell carcinoma10.2
49nose disease10.2
50peripheral nervous system neoplasm10.2

Graphical network of the top 20 diseases related to Recurrent Respiratory Papillomatosis:



Diseases related to recurrent respiratory papillomatosis

Symptoms for Recurrent Respiratory Papillomatosis

About this section

Drugs & Therapeutics for Recurrent Respiratory Papillomatosis

About this section

Drugs for Recurrent Respiratory Papillomatosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 7)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
CidofovirapprovedPhase 4, Phase 2, Phase 130113852-37-260613
Synonyms:
(2S)-3-Hydroxy-2-phosphonylmethoxypropyl-cytosine
(S)-(3-(4-amino-2-Oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
(S)-1-(3-Hydroxy-2-phosphonomethoxypropyl)cytosine
(S)-1-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
(S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine
(S)-1-[3-hydroxy-2-(phosphonylmethoxy)-propyl]cytosine
(S)-2-(4-Amino-2-oxo-1(2H)-pyrimidinyl-1-(hydroxymethyl)ethoxy)methyl phosphonic acid
(S)-HPMPC
(s)-[[2-(4-amino-2-oxo-1(2h)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
({[(S)-1-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine
1-(S)-[3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]-cytosine dihydrate
1-[(S)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine
113852-37-2
120362-37-0 (hydrochloride salt)
149394-66-1
AC-1666
AC1L1TLB
AC1Q6C68
AKOS005145721
C8H14N3O6P
CDV
CHEBI:3696
 
CHEMBL152
CID60613
Cidofovir
Cidofovir (Vistide)
Cidofovir (anhydrous)
Cidofovir Anhydrous
Cidofovir anhydrous
Cidofovirum
DB00369
Forvade
GS 0504
GS 504
GS-0504
GS-504
GS504
HPMPC
HSDB 7115
LS-106432
MolPort-005-935-597
NSC742135
S1516_Selleck
UNII-768M1V522C
Vistide
Vistide, Cidofovir
[(2S)-1-(4-amino-2-oxopyrimidin-1-yl)-3-hydroxypropan-2-yl]oxymethylphosphonic acid
[(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
[[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]phosphonic acid
2
Bevacizumabapproved, investigationalPhase 2, Phase 11820216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
3
Celecoxibapproved, investigationalPhase 2395169590-42-52662
Synonyms:
169590-42-5
184007-95-2
1oq5
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1Hpyrazol-1-yl] benzenesulfonamide
4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
AC-4228
AC1L1E6K
AI-525
BIDD:GT0408
BRD-K02637541-001-02-4
BSPBio_003596
Benzenesulfonamide,4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)
C07589
C105934
C17H14F3N3O2S
CCRIS 8679
CEL
CEP-33222
CHEBI:41423
CHEMBL118
CID2662
CPD000550473
Celebra
Celebrex
Celebrex (TN)
Celebrex, Celebra, Celecoxib
Celecox
Celecoxi
Celecoxib
Celecoxib (JAN/USAN/INN)
Celecoxib (SC-58635)
Celecoxib [Old RN]
Celecoxib [USAN]
Celecoxibum
Celocoxib
Célécoxib
D00567
DB00482
DivK1c_000893
Eurocox
FT-0080064
HMS1922G14
HMS2089L18
HMS2093I07
HMS502M15
HSDB 7038
I01-1033
IDI1_000893
KBio1_000893
KBio2_000912
 
KBio2_002351
KBio2_003480
KBio2_004919
KBio2_006048
KBio2_007487
KBio3_002830
KBio3_003037
KBioGR_000723
KBioGR_002351
KBioSS_000912
KBioSS_002354
LS-31667
MLS001165684
MLS001195656
MLS001304708
Medicoxib
MolPort-002-885-815
NCGC00091455-01
NCGC00091455-02
NCGC00091455-03
NCGC00091455-04
NCI60_041049
NINDS_000893
NSC719627
Onsenal
P-(5-P-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
Pfizer brand of celecoxib
S1261_Selleck
SAM002589995
SC 58635
SC-58553, SC-58635
SC-58635
SC58635
SMR000550473
SPBio_001512
SPECTRUM1503678
Solexa
Spectrum2_001576
Spectrum3_001996
Spectrum4_000182
Spectrum5_001324
Spectrum_000432
TL8001323
TPI-336
UNM-0000305813
Xilebao
YM 177
YM-177
YM177
ZINC02570895
cMAP_000027
celecoxib
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
4
Vitamin Aapproved, nutraceuticalPhase 238611103-57-4, 68-26-8445354
Synonyms:
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol
(2e,4e,6e,8e)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol
(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
.alpha.lin
.alpha.sterol
.beta.-Retinol
11103-57-4
13123-33-6
1341-18-0
1406-67-3
17104-91-5
1rbp
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraen-1-ol
3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-Isomer
4-06-00-04133 (Beilstein Handbook Reference)
53637-36-8
5979-23-7
68-26-8
95144_FLUKA
95144_SIGMA
95146_FLUKA
95146_SIGMA
A-Mulsal
A-Sol
A-Vi-Pel
A-Vitan
AC-11701
AC1L9HU3
AC1Q7BU9
ACON
ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1)
AR-1L3057
ATAV
Afaxin
Agiolan
Agoncal
Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol
Alcovit A
All Trans Retinol
All-trans retinol
All-trans-Retinol
Alphalin
Alphasterol
Anatola
Anatola A
Anti-infective vitamin
Antixerophthalmic vitamin
Antixerophthalmisches Vitamin
Aoral
Apexol
Apostavit
Aquasol A
Aquasol A Parenteral
Aquasynth
Atars
Avibon
Avita
Avitol
Axerol
Axerophthol
Axerophtholum
BIDD:PXR0102
BRN 0403040
Bentavit A
Biosterol
C00473
C17276
C20H30O
CCRIS 5444
CHEBI:17336
CHEMBL986
CID445354
Chocola A
Chocola a
Cylasphere
D014801
D06543
DB00162
Del-VI-A
Disatabs Tabs
Dofsol
Dohyfral A
EINECS 200-683-7
EINECS 234-328-2
Epiteliol
HMS1921B04
HMS2092L13
HMS501I08
HSDB 815
Hi-A-Vita
Homagenets Aoral
Homagenets aorl
Hydrovit A
IDI1_000486
LMPR01090001
LPK
LS-1578
Lard Factor
M.V.C. 9+3
M.V.I.-12
 
MLS001066379
MLS001074751
MolPort-001-785-962
Mvc Plus
Myvpack
NCGC00091784-01
NCGC00091784-02
NCGC00091784-03
NCGC00091784-04
NCGC00091784-05
NCGC00091784-06
NSC 122759
NSC122759
Nio-A-Let
Oleovitamin A
Ophthalamin
Plivit A
Prepalin
R7632_SIGMA
Retin-11,12-t2-ol (9CI)
Retinol
Retinol [INN:BAN]
Retinol solution
Retinol, all-trans- (8CI)
Retinol-(cellular-retinol-binding-protein)
Retinolo
Retinolo [DCIT]
Retinolum
Retinolum [INN-Latin]
Retrovitamin A
Ro-a-vit
Rovimix A 500
SDCCGMLS-0066724.P001
SMP2_000102
SMR000112036
SPECTRUM1501203
ST057232
Sehkraft A
Solu-A
Spectrum5_000993
Spectrum5_001997
Super A
Testavol
Testavol S
Thalasphere
UNII-81G40H8B0T
UNII-G2SH0XKK91
Vaflol
Vafol
Veroftal
Vi-.alpha.
Vi-Alpha
Vi-Dom-A
Vi-a
Vio-A
Vitamin A
Vitamin A (Feed)
Vitamin A (USP)
Vitamin A alcohol
Vitamin A alcohol (VAN)
Vitamin A cryst
Vitamin A palmitate
Vitamin A1
Vitamin A1 alcohol
Vitamin A1 alcohol, all trans
Vitamin a
Vitamin- A
Vitamin- A alcohol
Vitamin- A alcohol solution
Vitamin- A1
Vitamin-?A
Vitamin-?A alcohol
Vitamin-?A alcohol solution
Vitamin-?A1
Vitamine A
Vitaminum A
Vitavel A
Vitavel-A
Vitpex
Vogan
Vogan-Neu
Vogan-nu
WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1
Wachstumsvitamin
ZINC03831417
Zinosan N
[11,12-3H]-Retinol
alin
all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol
all-trans-Retinol
all-trans-Retinyl alcohol
all-trans-Vitamin A
all-trans-Vitamin A alcohol
all-trans-Vitamin A1
all-trans-retinol
all-trans-retinyl alcohol
all-trans-vitamin A alcohol
b-Retinol
beta-Retinol
retinol
tROL
trans-Retinol
trans-Retinol acid (Vitamin A)
trans-Vitamin A alcohol
trans-retinol
5Cyclooxygenase 2 InhibitorsPhase 2517
6Retinol palmitatePhase 2386
7retinolNutraceuticalPhase 2386

Interventional clinical trials:

(show all 19)
idNameStatusNCT IDPhase
1Use of Cidofovir for Recurrent Respiratory PapillomatosisCompletedNCT00205374Phase 4
2Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")TerminatedNCT00747461Phase 4
3Effect of Vaccination in Patients With Recurrent Respiratory PapillomatosisActive, not recruitingNCT01375868Phase 3
44-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in ChildrenNot yet recruitingNCT01995721Phase 3
5Propranolol Administration in Pediatric Patients With Recurrent Respiratory PapillomatosisWithdrawnNCT01058317Phase 2, Phase 3
6A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory PapillomatosisCompletedNCT00038714Phase 2
7Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory PapillomatosisCompletedNCT00571701Phase 2
8Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory PapillomatosisRecruitingNCT02555800Phase 2
9Study of Anti-PD-1 Therapy for HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal and/or Pulmonary InvolvementNot yet recruitingNCT02632344Phase 2
10New Therapy of Laryngeal Papilloma In ChildrenTerminatedNCT00591305Phase 2
11Bevacizumab for Treatment of Recurrent Respiratory Papillomatosis (RRP)CompletedNCT01020747Phase 1
12Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat)CompletedNCT00001126Phase 1
13Optical Coherence Tomography of the Airway for Lung Cancer or Lung DiseaseWithdrawnNCT00733252Phase 1
14Multi-Center, Randomized Trial of the Pulsed Dye Laser for JORRPCompletedNCT00550914
15Human Papillomatosis Genotyping of Children in ThailandCompletedNCT01304966
16Human Papillomavirus 6/11 in the Lower Airway of NeonatesCompletedNCT00549250
17Recurrent Respiratory Papillomatosis and Extraesophageal RefluxRecruitingNCT02592902
18Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous LesionsRecruitingNCT02217358
19Therapeutic Treatment With Human Papillomavirus Quadrivalent Vaccine for Recurrent Respiratory PapillomatosisWithdrawnNCT00829608Phase 0

Search NIH Clinical Center for Recurrent Respiratory Papillomatosis

Genetic Tests for Recurrent Respiratory Papillomatosis

About this section

Anatomical Context for Recurrent Respiratory Papillomatosis

About this section

MalaCards organs/tissues related to Recurrent Respiratory Papillomatosis:

33
Lung, T cells, Testes, Trachea, Spinal cord

Animal Models for Recurrent Respiratory Papillomatosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Recurrent Respiratory Papillomatosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.3EGFR, HEXB, HLA-DQB1, IL2

Publications for Recurrent Respiratory Papillomatosis

About this section

Articles related to Recurrent Respiratory Papillomatosis:

(show top 50)    (show all 349)
idTitleAuthorsYear
1
Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis. (26151558)
2015
2
A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion. (24942884)
2014
3
Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. (24964770)
2014
4
Clinical course of recurrent respiratory papillomatosis: Comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. (24955561)
2014
5
Rapid response to systemic bevacizumab therapy in recurrent respiratory papillomatosis. (25289079)
2014
6
Decreased Langerhans Cell Responses to IL-36I^: Altered Innate Immunity in Patients with Recurrent Respiratory Papillomatosis. (24950037)
2014
7
Identical human papillomavirus (HPV) genomic variants persist in recurrent respiratory papillomatosis for up to 22 years. (23204170)
2013
8
Photoangiolytic laser treatment of recurrent respiratory papillomatosis: a scaled assessment. (23102824)
2013
9
FRET-based detection and genotyping of HPV-6 and HPV-11 causing recurrent respiratory papillomatosis. (23473839)
2013
10
Surgical treatment and adjuvant therapies of recurrent respiratory papillomatosis. (24141682)
2013
11
HPV and recurrent respiratory papillomatosis: A modern virus and a serious disease with controversial management. (24139588)
2013
12
Risk factors for the development and severity of juvenile-onset recurrent respiratory papillomatosis: A systematic review. (24367938)
2013
13
Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis. (22566012)
2012
14
Safety and dosing of bevacizumab (avastin) for the treatment of recurrent respiratory papillomatosis. (23012897)
2012
15
Risk factors of juvenile onset recurrent respiratory papillomatosis in the lower respiratory tract. (23044312)
2012
16
Does food intolerance play a role in recurrent respiratory papillomatosis? (22311847)
2012
17
Natural progression of dysplasia in adult recurrent respiratory papillomatosis. (21493426)
2011
18
Papillomavirus-specific CD4+ T cells exhibit reduced STAT-5 signaling and altered cytokine profiles in patients with recurrent respiratory papillomatosis. (21531896)
2011
19
Recurrent respiratory papillomatosis: an overview. (20517629)
2010
20
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. (20553528)
2010
21
The role of HPV type in Recurrent Respiratory Papillomatosis. (19800138)
2010
22
Epidemiology of recurrent respiratory papillomatosis. (20553527)
2010
23
Palliative aspects of recurrent respiratory papillomatosis. (19134490)
2009
24
High-resolution ultrasound in the evaluation of pediatric recurrent respiratory papillomatosis. (19289702)
2009
25
Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion. (19284366)
2009
26
Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children. (19193450)
2009
27
Time course of juvenile onset recurrent respiratory papillomatosis caused by human papillomavirus. (18174855)
2008
28
Recurrent respiratory papillomatosis complicated by aspergillosis: a case report with review of literature. (18296803)
2008
29
Recurrent respiratory papillomatosis in pregnancy: a case of emergent airway management. (18561109)
2008
30
Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis. (17277618)
2007
31
Unusual malignant transformation of juvenile recurrent respiratory papillomatosis. (17275567)
2007
32
Can zinc be an adjuvant therapy for juvenile onset recurrent respiratory papillomatosis? (17560665)
2007
33
Identification of HPV DNA in patients with juvenile-onset recurrent respiratory papillomatosis using SYBR Green real-time PCR. (16137771)
2006
34
Cidofovir for the treatment of recurrent respiratory papillomatosis: a review of the literature. (16006276)
2005
35
HLA alleles, IFN-gamma responses to HPV-11 E6, and disease severity in patients with recurrent respiratory papillomatosis. (15336778)
2004
36
Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis. (15567056)
2004
37
Pulsed-dye laser in the treatment of recurrent respiratory papillomatosis of the larynx. (14503089)
2003
38
Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children. (12925342)
2003
39
Powered instrumentation in the treatment of recurrent respiratory papillomatosis: an alternative to the carbon dioxide laser. (11926919)
2002
40
Recurrent respiratory papillomatosis. (10851821)
2000
41
Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment. (10984775)
2000
42
Pathological case of the month. Recurrent respiratory papillomatosis. (9559722)
1998
43
Risk factors for juvenile onset recurrent respiratory papillomatosis. (9613648)
1998
44
Treatment of recurrent respiratory papillomatosis with indole-3-carbinol. (9242883)
1997
45
Tracheotomy in children with juvenile-onset recurrent respiratory papillomatosis: the Children's Hospital of Pittsburgh experience. (8546418)
1996
46
Role of cesarean section in prevention of recurrent respiratory papillomatosis--is there one? (8882107)
1996
47
Acyclovir in the treatment of recurrent respiratory papillomatosis. A pilot study. (8154772)
1994
48
13-Cis-retinoic acid plus interferon-alpha 2a in recurrent respiratory papillomatosis. (8182767)
1994
49
Isotretinoin therapy for recurrent respiratory papillomatosis. (8166969)
1994
50
Complications of laser surgery for recurrent respiratory papillomatosis. (3688749)
1987

Variations for Recurrent Respiratory Papillomatosis

About this section

Expression for genes affiliated with Recurrent Respiratory Papillomatosis

About this section
Search GEO for disease gene expression data for Recurrent Respiratory Papillomatosis.

Pathways for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Pathways related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 13)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.7HLA-DQB1, HLA-DRB1
29.6HLA-DRB1, IL2
39.6HLA-DRB1, IL2
4
AhR pathway (WikiPathways)
Show member pathways
9.5HLA-DRB1, IL2
5
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IL2
69.2HLA-DQB1, HLA-DRB1, IL2
79.2HLA-DQB1, HLA-DRB1, IFNA2
8
Show member pathways
9.2HLA-DQB1, HLA-DRB1, IFNA2
99.0EGFR, IFNA2, IL2
10
Show member pathways
8.7EGFR, HLA-DQB1, HLA-DRB1, IL2
11
Show member pathways
8.7EGFR, HLA-DQB1, HLA-DRB1, IL2
12
Show member pathways
8.7HLA-DQB1, HLA-DRB1, IFNA2, IL2
13
Show member pathways
8.7HLA-DQB1, HLA-DRB1, IFNA2, IL2

GO Terms for genes affiliated with Recurrent Respiratory Papillomatosis

About this section

Cellular components related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II protein complexGO:004261310.1HLA-DQB1, HLA-DRB1
2integral component of lumenal side of endoplasmic reticulum membraneGO:007155610.1HLA-DQB1, HLA-DRB1
3ER to Golgi transport vesicle membraneGO:001250710.1HLA-DQB1, HLA-DRB1
4endocytic vesicle membraneGO:003066610.0HLA-DQB1, HLA-DRB1
5clathrin-coated endocytic vesicle membraneGO:003066910.0HLA-DQB1, HLA-DRB1
6trans-Golgi network membraneGO:003258810.0HLA-DQB1, HLA-DRB1
7transport vesicle membraneGO:00306589.6HLA-DQB1, HLA-DRB1
8Golgi membraneGO:00001398.5EGFR, EXT1, HLA-DQB1, HLA-DRB1

Biological processes related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

(show all 8)
idNameGO IDScoreTop Affiliating Genes
1antigen processing and presentation of peptide or polysaccharide antigen via MHC class IIGO:000250410.3HLA-DQB1, HLA-DRB1
2immunoglobulin production involved in immunoglobulin mediated immune responseGO:000238110.3HLA-DQB1, HLA-DRB1
3humoral immune response mediated by circulating immunoglobulinGO:000245510.2HLA-DQB1, HLA-DRB1
4T cell costimulationGO:003129510.1HLA-DQB1, HLA-DRB1
5antigen processing and presentationGO:001988210.1HLA-DQB1, HLA-DRB1
6positive regulation of phosphorylationGO:00423279.3EGFR, IFNA2
7immune responseGO:00069559.2HLA-DQB1, HLA-DRB1, IL2
8cytokine-mediated signaling pathwayGO:00192219.2HLA-DQB1, HLA-DRB1, IFNA2

Molecular functions related to Recurrent Respiratory Papillomatosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1MHC class II receptor activityGO:003239510.0HLA-DQB1, HLA-DRB1
2peptide antigen bindingGO:00426059.7HLA-DQB1, HLA-DRB1
3acetylglucosaminyltransferase activityGO:00083759.0EXT1, HEXB

Sources for Recurrent Respiratory Papillomatosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet